Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.00    0.00 (0.00%)
Bid:
227.50
Ask:
228.50
Spread: 1.00 (0.44%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Trading Update

12 Nov 2015 07:00

RNS Number : 4277F
Morgan Advanced Materials PLC
12 November 2015
 



 

Press Release

Trading Update

Morgan Advanced Materials plc

12th November 2015

 

 

Morgan Advanced Materials plc, the advanced materials company, is today issuing the following trading update covering the period from 1st July 2015 to 11th November 2015.

 

Trading conditions in the period since the half year have weakened across the Group with North America and China particularly affected by deteriorating demand. Overall our order book has mirrored this weakness, but with a mixed profile across the geographies, businesses and end markets in which we operate.

 

At the end of October the YTD book to bill ratio was 1.00 (June 2015 -1.03). The outstanding order book at the end of October was 5.3% below last year (June 2015 - 5.7% higher than the June 2014). Given this order profile, the Group expects that reported revenue in the second half of the year will be c7% below the first half of 2015 and that EBITA before restructuring and one-offs will be around the lower end of the range of analyst expectations.

 

The North American region has been the most affected by economic slowdown. General industrial demand weakness has been seen across our business over the last four months particularly oil and gas, transportation and mining markets.

 

In Europe the Thermal Ceramics business has continued to trade well, offset by weak demand in Technical Ceramics, Seals and Bearings and Composites and Defence Systems.

 

Asia/ROW has continued to see very weak demand in China, which has impacted both the products manufactured in-region for industrial markets and also those sold in to China from Morgan businesses in North America and Europe. The rest of Asia has shown some weakness in parts of its demand environment, but overall has been fairly resilient. Weak economic conditions in South America, particularly in Brazil and Argentina, are impacting the performance of our mainly industrial business in the region.

 

The Group is cautious about the trading and macro-economic environment for the rest of this year, and into 2016, and the Group has undertaken a range of cost reduction measures in line with this weakening economic environment and will continue to take further action as necessary. The cash cost for these restructuring and one-off items is estimated to be low, in the region of £3 million. Against this challenging market, the Group continues to invest in R&D and profitable growth opportunities which are critical for the future. Such investment is underpinned by solid cash flow and a strong balance sheet, with low net debt estimated to be c1.5 times EBITDA at the end of 2015.

 

Morgan's preliminary results for the year ended 31st December 2015 will be announced on 23rd February 2016.

 

(Note:

Current market expectations compiled from analyst notes for EBITA before restructuring and one-off items range from £110.0 million to £121.5 million).

 

 

 

 

 

 

For further enquiries:

 

Pete Raby/Kevin Dangerfield

Morgan Advanced Materials plc

01753 837000

Mike Smith/Nina Coad

Brunswick

0207 404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKDDDFBDDODD
Date   Source Headline
30th Nov 20113:26 pmRNSScrip Dividend Price
30th Nov 20111:16 pmRNSHolding(s) in Company
29th Nov 20114:06 pmRNSHolding(s) in Company
25th Nov 20119:41 amRNSDirector/PDMR Shareholding
14th Nov 20117:00 amRNSInterim Management Statement
18th Oct 20119:29 amRNSHolding(s) in Company
5th Oct 20115:50 pmRNSHolding(s) in Company
4th Oct 20119:57 amRNSDirector/PDMR Shareholding
12th Sep 201112:16 pmRNSDirector/PDMR Shareholding
31st Aug 20114:08 pmRNSHolding(s) in Company
24th Aug 201112:33 pmRNSDirector/PDMR Shareholding
11th Aug 20119:45 amRNSHalf Yearly Report
1st Aug 20119:35 amRNSTotal Voting Rights
20th Jul 20113:10 pmRNSDirector/PDMR Shareholding
13th Jul 20117:00 amRNSTrading Statement
8th Jul 20115:40 pmRNSDirector/PDMR Shareholding
8th Jul 20115:27 pmRNSTotal Voting Rights
1st Jul 201111:06 amRNSIssue of Equity
15th Jun 201112:03 pmRNSBlocklisting Interim Review
25th May 20119:57 amRNSScrip Dividend Price
11th May 20113:32 pmRNSResult of AGM
10th May 20117:00 amRNSInterim Management Statement
18th Apr 20112:59 pmRNSAnnual Information Update
8th Apr 20113:30 pmRNSDirector/PDMR Shareholding
8th Apr 201112:23 pmRNSHolding(s) in Company
8th Apr 201112:21 pmRNSDirector/PDMR Shareholding
6th Apr 20115:00 pmRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSAnnual Financial Report
31st Mar 20117:00 amRNSCapital Markets Presentation
25th Mar 20114:01 pmRNSHolding(s) in Company
25th Mar 20113:57 pmRNSDirector/PDMR Shareholding
24th Mar 20115:10 pmRNSDirector/PDMR Shareholding
24th Mar 20113:03 pmRNSDirector/PDMR Shareholding
15th Mar 20116:00 pmRNSHolding(s) in Company
15th Mar 20115:58 pmRNSHolding(s) in Company
4th Mar 20115:09 pmRNSDirector/PDMR Shareholding
28th Feb 20115:27 pmRNSTotal Voting Rights
16th Feb 20117:00 amRNSFull Year Results
31st Jan 201110:26 amRNSTotal Voting Rights
28th Jan 20111:33 pmRNSAppointment as a Non-Executive Director
17th Jan 20113:20 pmRNSHolding(s) in Company
17th Jan 20113:20 pmRNSDirector/PDMR Shareholding
14th Jan 20117:00 amRNSAcquisition
13th Jan 201110:15 amRNSAppointment of Tim Stevenson to Johnson Matthey
12th Jan 20111:21 pmRNSHolding(s) in Company
12th Jan 20119:34 amRNSDirector/PDMR Shareholding
12th Jan 20119:30 amRNSTotal Voting Rights
5th Jan 201110:40 amRNSIssue of Shares under Scrip Dividend Scheme
15th Dec 20104:04 pmRNSBlocklisting Interim Review
8th Dec 20104:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.